SGSM2 and breast cancer: These data were not consistent with CDH1 expression data, which was more highly expressed in IDC than in ILC (Figure S8(b), ***P < 0.001), and even in CDH1-positive BC patients, a significant correlation with SGSM2 was not found (Figure S9(a,b)).